Key result
Oral captopril reduces mean arterial pressure in normotensive volunteers, inhibiting plasma-converting enzyme for 6 hours.
Why the study?
The relationships between captopril's haemodynamic effects and its impact on sympathetic activity, the renin-angiotensin-aldosterone system, and plasma-converting enzyme activity in normotensive sodium-replete volunteers were investigated.
Does captopril alter haemodynamics and the renin-angiotensin-aldosterone system in normotensive sodium-replete volunteers?
Does captopril alter haemodynamics and the renin-angiotensin-aldosterone system in normotensive sodium-replete volunteers?
Captopril effectively lowers blood pressure and inhibits converting enzyme in normotensive volunteers, with enzyme inhibition serving as a reliable index of captopril concentration.
Answers are grounded in this paper and cite their sources.
Should not change practice from normotensive volunteer data; leaves open translation to hypertensive patients.
Captopril (SQ 14 225) was administered to normotensive, sodium-replete volunteers in order to investigate the relationships between its haemodynamic effects and effects on sympathetic activity, the renin-angiotensin-aldosterone system, and plasma-converting enzyme activity. Following the administration of captopril (25 mg) orally, mean arterial pressure fell (supine 89.1 +/- 5.9 to 81.1 +/- 3.3 mm Hg, p less than 0.01; erect 98.5 +/- 5.5 to 87.4 +/- 6.7 mm Hg, p less than 0.01) but heart rate did not change. Plasma noradrenaline rose; plasma renin activity and angiotensin I concentration rose, while angiotensin II and aldosterone fell; plasma-converting enzyme was inhibited for 6 h. The extent of blood pressure reduction and converting enzyme inhibition was closely correlated (r = 0.92, p less than 0.001). Plasma captopril concentration was directly related to converting enzyme inhibition in an in vitro study using plasma from the same subjects. In the absence of a convenient assay of captopril, converting enzyme may be used as an index of captopril concentration in the further study of kinetic and dynamic relationships.
No takes yet. Share an insight, caveat, or question.
Shepherd et al. (1982) studied Normotensive. Captopril was evaluated on Mean arterial pressure (p=<0.01). Oral captopril reduced supine and erect mean arterial pressure in normotensive volunteers and inhibited plasma-converting enzyme for 6 hours.
Synapse has enriched 10 related papers. Consider them for comparative context: